For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 7,780,698 | |||
| General and administrative | 6,869,996 | |||
| Total operating expenses | 14,650,694 | |||
| Loss from operations | -14,650,694 | |||
| Investment income, net | 155,666 | |||
| Total other income, net | 155,666 | |||
| Net loss | -14,495,028 | |||
| Basic EPS | -6.83 | |||
| Diluted EPS | -6.83 | |||
| Basic Average Shares | 2,123,344 | |||
| Diluted Average Shares | 2,123,344 | |||
Imunon, Inc. (IMNN)
Imunon, Inc. (IMNN)